Home / Caspofungin / United States
US ATC J02AX04 · updated 2 Nov 2026
Caspofungin shortage in United States
Is there a Caspofungin shortage in United States?
Yes. As of 2 Nov 2026, 3 Caspofungin products are reported short in United States, the first since 12 Jan 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Switzerland, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10) discontinuation | Fresenius Kabi USA, LLC | 12 Jan 2026 | not given | Not stated |
| US | Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94) discontinuation | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | 30 Jun 2026 | not given | Not stated |
| US | Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94) discontinuation | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | 30 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).